|
Opexa Therapeutics, Inc. Files Registration Statement for Rights Offering
MarketWatch Each such Series L warrant holder will receive one subscription right for each share of common stock into which the Series L warrants are exercisable as of the record date. Holders who fully exercise their basic subscription rights will be entitled, if … |
